🔎 Trials Near Me

Hjem › Akut bifænotypisk leukæmi › Connecticut

Akut bifænotypisk leukæmi kliniske forsøg i Connecticut

3 studier for Akut bifænotypisk leukæmi søger deltagere på steder i Connecticut.

Byer i Connecticut

Officiel studietekst (engelsk)

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Yale University, New Haven
RekruttererFase 2
365 Days · Alle køn · Opdateret 25. sep. 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Connecticut Children's Medical Center, Hartford
  • Yale University, New Haven
RekruttererFase 3
365 Days – 25 Years · Alle køn · Opdateret 25. aug. 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Connecticut Children's Medical Center, Hartford
  • Yale University, New Haven
RekruttererFase 1/2
Op til 22 år · Alle køn · Opdateret 25. aug. 2026 · NCT04726241

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.